|
US5504188A
(en)
*
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
|
AR002976A1
(es)
*
|
1995-03-31 |
1998-05-27 |
Lilly Co Eli |
Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
|
|
US5631347A
(en)
*
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
|
US5869604A
(en)
*
|
1995-11-09 |
1999-02-09 |
Georgia Institute Of Technology |
Crystallization and purification of polypeptides
|
|
US6043214A
(en)
*
|
1997-03-20 |
2000-03-28 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
|
DE69806582T2
(de)
*
|
1997-03-20 |
2003-02-13 |
Novo Nordisk A/S, Bagsvaerd |
Verfahren zur herstellung eines therapeutischen puders durch copräzipitation von insulin und einem absorptionsverstärker
|
|
ES2202910T3
(es)
*
|
1997-11-12 |
2004-04-01 |
Alza Corporation |
Composiciones de farmacos regulados para la administracion transdermica por electrotranporte.
|
|
RU2205188C2
(ru)
|
1998-06-30 |
2003-05-27 |
Ново Нордиск А/С |
Затравочные кристаллы для получения пептидов или протеинов
|
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
PT1121144E
(pt)
*
|
1998-10-16 |
2002-11-29 |
Novo Nordisk As |
Preparados de insulina concentrada estavel para administracao pulmonar
|
|
PL347171A1
(en)
*
|
1998-10-16 |
2002-03-25 |
Novo Nordisk As |
Insulin preparations for pulmonary delivery containing menthol
|
|
US6635617B1
(en)
|
1998-10-16 |
2003-10-21 |
Novo Nordisk A/S |
Insulin preparations for pulmonary delivery containing menthol
|
|
US6211144B1
(en)
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
|
US20030054015A1
(en)
*
|
2000-12-25 |
2003-03-20 |
Shinichiro Haze |
Sympathetic-activating perfume composition
|
|
DK1772464T3
(da)
*
|
2001-02-09 |
2009-12-14 |
Genentech Inc |
Fremgangsmåder til identificering af indirekte agonister af IGF-1
|
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US20030068361A1
(en)
*
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
|
EP1444219A1
(en)
|
2001-10-12 |
2004-08-11 |
Novo Nordisk A/S |
Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
|
|
US7601688B2
(en)
*
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
JP4629657B2
(ja)
|
2003-04-11 |
2011-02-09 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型化活性化合物
|
|
CN1882356B
(zh)
|
2003-11-20 |
2015-02-25 |
诺沃挪第克公司 |
对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
|
|
US7875700B2
(en)
|
2004-07-19 |
2011-01-25 |
Biocon Limited |
Cation complexes of insulin compound conjugates, formulation and uses thereof
|
|
WO2006020580A2
(en)
*
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
|
CA2614116A1
(en)
|
2005-07-04 |
2007-01-11 |
Novo Nordisk A/S |
Novel medicaments
|
|
EP1910317B1
(en)
|
2005-07-20 |
2013-07-03 |
Eli Lilly And Company |
1-amino linked compounds
|
|
SI1951658T1
(sl)
|
2005-11-17 |
2012-11-30 |
Lilly Co Eli |
Antagonisti glukagonskega receptorja priprava interapevtska uporaba
|
|
JP5312054B2
(ja)
|
2006-03-15 |
2013-10-09 |
ノボ・ノルデイスク・エー／エス |
アミリンとインスリンの混合物
|
|
NZ570524A
(en)
|
2006-03-28 |
2011-08-26 |
High Point Pharmaceuticals Llc |
Benzothiazoles having histamine H3 receptor activity
|
|
US8927015B2
(en)
*
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
|
AU2007244971B2
(en)
|
2006-04-24 |
2012-01-19 |
Eli Lilly And Company |
Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
PT2079732E
(pt)
|
2006-05-29 |
2012-02-02 |
High Point Pharmaceuticals Llc |
3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)- piridazina, os seus sais e solvatos e a sua utilização a título de antagonista do receptor h3 de histamina
|
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
JP2011504871A
(ja)
|
2007-06-01 |
2011-02-17 |
ノボ・ノルデイスク・エー／エス |
固体又は半固体担体中にペプチド薬剤を含む自然に分散可能なプレコンセントレイト
|
|
KR20100017667A
(ko)
|
2007-06-01 |
2010-02-16 |
노보 노르디스크 에이/에스 |
안정한 비-수성의 약학 조성물
|
|
US9034818B2
(en)
*
|
2007-06-13 |
2015-05-19 |
Novo Nordisk A/S |
Pharmaceutical formulations comprising an insulin derivative
|
|
MX2010003979A
(es)
*
|
2007-10-16 |
2010-06-02 |
Biocon Ltd |
Composicion farmaceutica oralmente administrable y proceso para su preparacion.
|
|
US20090271021A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Popp Shane M |
Execution system for the monitoring and execution of insulin manufacture
|
|
ES2477552T3
(es)
|
2008-09-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
|
|
WO2010062308A1
(en)
|
2008-10-28 |
2010-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase and methods of use thereof
|
|
MX2011005037A
(es)
|
2008-11-21 |
2011-06-16 |
High Point Pharmaceuticals Llc |
Compuestos de adamantilo benzamida.
|
|
MX2011007929A
(es)
|
2009-01-28 |
2011-08-17 |
Smartcells Inc |
Sistemas basados en conjugados para entrega farmacologica controlada.
|
|
WO2010088286A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Synthetic conjugates and uses thereof
|
|
EP2408808A4
(en)
|
2009-03-20 |
2015-05-06 |
Smartcells Inc |
TERMINAL-FUNCTIONALIZED CONJUGATES AND THEIR USE
|
|
KR20120055653A
(ko)
*
|
2009-08-11 |
2012-05-31 |
바이오콘 리미티드 |
크로마토그래피 방법 및 그의 정제된 화합물
|
|
JP6110312B2
(ja)
|
2011-02-01 |
2017-04-05 |
ノヴォ ノルディスク アー／エス |
インスリンの精製
|
|
US10130684B2
(en)
|
2011-02-03 |
2018-11-20 |
Pharmedica Ltd. |
Oral dissolving films for insulin administration, for treating diabetes
|
|
WO2012115641A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
|
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
|
CN102219851B
(zh)
*
|
2011-05-09 |
2012-05-30 |
甘李药业有限公司 |
甘精胰岛素结晶的制备方法
|
|
EP2925345B1
(en)
|
2012-12-03 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
|
CN103342746B
(zh)
*
|
2013-07-26 |
2014-07-30 |
珠海联邦制药股份有限公司 |
一种制备稳定的门冬胰岛素结晶的方法
|
|
EP3077414B1
(en)
|
2013-12-04 |
2020-06-17 |
Merck Sharp & Dohme Corp. |
Method for preparing crystalline insulin
|
|
EP2990033A1
(fr)
*
|
2014-08-26 |
2016-03-02 |
Carlina Technologies |
Procédé de préparation de nanoprécipites de peptide ou protéine de faible poids moléculaire
|
|
EP3185887B1
(en)
|
2014-08-26 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Method for preparing crystalline insulin or insulin analog compositions
|
|
CN104193819B
(zh)
*
|
2014-09-03 |
2017-05-17 |
韩飞 |
胰岛素二聚体晶体的合成和保存方法
|
|
CN104761632A
(zh)
*
|
2015-04-14 |
2015-07-08 |
珠海联邦制药股份有限公司 |
一种地特胰岛素结晶的制备方法及应用
|
|
CN106117345B
(zh)
*
|
2015-05-05 |
2020-11-24 |
宜昌东阳光长江药业股份有限公司 |
一种制备甘精胰岛素结晶的方法
|
|
CN104892749B
(zh)
*
|
2015-06-16 |
2019-02-05 |
珠海联邦制药股份有限公司 |
一种德谷胰岛素结晶的制备方法及应用
|
|
CN105753966A
(zh)
*
|
2016-05-05 |
2016-07-13 |
通化东宝药业股份有限公司 |
一种重组人胰岛素结晶的制备方法
|
|
US11413352B2
(en)
|
2017-12-18 |
2022-08-16 |
Merck, Sharp & Dohme LLC |
Conjugate based systems for controlled insulin delivery
|
|
EP3727424A4
(en)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
CONJUGATE-BASED SYSTEMS FOR CONTROLLED INSULIN RELEASE
|
|
KR20220161422A
(ko)
|
2020-03-31 |
2022-12-06 |
프로토머 테크놀로지스 인크. |
비시날 디올에 대한 선택적인 반응을 위한 접합체
|
|
CA3198757A1
(en)
|
2020-11-19 |
2022-05-27 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and insulin analogs
|
|
CN113896784B
(zh)
*
|
2021-10-18 |
2024-04-16 |
合肥天麦生物科技发展有限公司 |
一种胰岛素结晶的制备方法及其产品
|
|
KR20250005573A
(ko)
|
2022-05-18 |
2025-01-09 |
프로토머 테크놀로지스 인크. |
방향족 붕소-함유 화합물 및 관련 인슐린 유사체
|